Trade LifeStance Health Group - LFST CFD
Add to favourite- Summary
- Historical Data
- Events
- Income Statement
- Balance Sheet
- Cash Flow
- Ownership
Spread | 0.07 | ||||||||
Long position overnight fee
Long position overnight fee
Go to platform | -0.026207% | ||||||||
Short position overnight fee
Short position overnight fee
Go to platform | 0.003985% | ||||||||
Overnight fee time | 22:00 (UTC) | ||||||||
Min traded quantity | 1 | ||||||||
Currency | USD | ||||||||
Margin | 5% | ||||||||
Stock exchange | United States of America | ||||||||
Commission on trade | 0% |
*Information provided by Capital.com
Lifestance Health Group Inc ESG Risk Ratings
‘D’ score indicates poor relative ESG performance and insufficient degree of transparency in reporting material ESG data publicly.
Prev. Close* | 6.61 |
Open* | 6.63 |
1-Year Change* | 17.55% |
Day's Range* | 6.63 - 6.82 |
52 wk Range | 4.22-9.59 |
Average Volume (10 days) | 737.00K |
Average Volume (3 months) | 17.72M |
Market Cap | 2.33B |
P/E Ratio | -100.00K |
Shares Outstanding | 378.61M |
Revenue | 1.00B |
EPS | -0.52 |
Dividend (Yield %) | N/A |
Beta | -100.00K |
Next Earnings Date | Feb 26, 2024 |
All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
Date | Close | Change | Change (%) | Open | High | Low |
---|---|---|---|---|---|---|
Dec 8, 2023 | 6.66 | 0.23 | 3.58% | 6.43 | 6.83 | 6.43 |
Dec 7, 2023 | 6.61 | -0.01 | -0.15% | 6.62 | 6.78 | 6.47 |
Dec 6, 2023 | 6.63 | 0.32 | 5.07% | 6.31 | 6.69 | 6.31 |
Dec 5, 2023 | 6.44 | 0.13 | 2.06% | 6.31 | 6.58 | 6.31 |
Dec 4, 2023 | 6.59 | 0.18 | 2.81% | 6.41 | 6.61 | 6.37 |
Dec 1, 2023 | 6.50 | 0.01 | 0.15% | 6.49 | 6.62 | 6.38 |
Nov 30, 2023 | 6.84 | 0.20 | 3.01% | 6.64 | 6.86 | 6.62 |
Nov 29, 2023 | 6.73 | 0.09 | 1.36% | 6.64 | 6.85 | 6.64 |
Nov 28, 2023 | 6.65 | 0.26 | 4.07% | 6.39 | 6.71 | 6.37 |
Nov 27, 2023 | 6.58 | 0.20 | 3.13% | 6.38 | 6.62 | 6.37 |
Nov 24, 2023 | 6.50 | 0.32 | 5.18% | 6.18 | 6.58 | 6.12 |
Nov 22, 2023 | 6.36 | 0.28 | 4.61% | 6.08 | 6.42 | 6.04 |
Nov 21, 2023 | 6.12 | 0.15 | 2.51% | 5.97 | 6.15 | 5.97 |
Nov 20, 2023 | 6.16 | 0.16 | 2.67% | 6.00 | 6.27 | 6.00 |
Nov 17, 2023 | 6.14 | 0.01 | 0.16% | 6.13 | 6.22 | 6.04 |
Nov 16, 2023 | 6.08 | 0.11 | 1.84% | 5.97 | 6.10 | 5.86 |
Nov 15, 2023 | 6.10 | 0.26 | 4.45% | 5.84 | 6.39 | 5.84 |
Nov 14, 2023 | 6.17 | 0.38 | 6.56% | 5.79 | 6.20 | 5.79 |
Nov 13, 2023 | 5.62 | 0.19 | 3.50% | 5.43 | 5.64 | 5.36 |
Nov 10, 2023 | 5.57 | 0.16 | 2.96% | 5.41 | 5.66 | 5.40 |
LifeStance Health Group Events
Time (UTC) | Country | Event |
---|---|---|
Monday, February 26, 2024 | ||
Time (UTC) 11:00 | Country US
| Event Q4 2023 Lifestance Health Group Inc Earnings Release Q4 2023 Lifestance Health Group Inc Earnings ReleaseForecast -Previous - |
- Annual
- Quarterly
2022 | 2021 | 2020 | 2019 | |
---|---|---|---|---|
Total revenue | 859.542 | 667.511 | 377.217 | 212.518 |
Revenue | 859.542 | 667.511 | 377.217 | 212.518 |
Total Operating Expense | 1081.54 | 972.026 | 398.965 | 199.463 |
Selling/General/Admin. Expenses, Total | 373.902 | 430.54 | 311.303 | 179.633 |
Depreciation / Amortization | 69.198 | 54.136 | 31.045 | 6.095 |
Unusual Expense (Income) | 15.913 | 21.347 | 37.184 | 2.186 |
Other Operating Expenses, Total | 622.525 | 466.003 | 19.433 | 11.549 |
Operating Income | -221.996 | -304.515 | -21.748 | 13.055 |
Interest Income (Expense), Net Non-Operating | -8.828 | -24.511 | -22.132 | -5.409 |
Other, Net | -1.906 | -4.079 | -0.531 | 0.229 |
Net Income Before Taxes | -232.73 | -333.105 | -44.411 | 7.875 |
Net Income After Taxes | -215.564 | -307.197 | -38.07 | 5.669 |
Net Income Before Extra. Items | -215.564 | -307.197 | -38.07 | 5.669 |
Net Income | -215.564 | -307.197 | -38.07 | 5.669 |
Total Adjustments to Net Income | 0 | -36.75 | -273.244 | -64.573 |
Income Available to Common Excl. Extra. Items | -215.564 | -343.947 | -311.314 | -58.904 |
Income Available to Common Incl. Extra. Items | -215.564 | -343.947 | -311.314 | -58.904 |
Diluted Net Income | -215.564 | -343.947 | -311.314 | -58.904 |
Diluted Weighted Average Shares | 355.278 | 327.523 | 373.649 | 373.649 |
Diluted EPS Excluding Extraordinary Items | -0.60675 | -1.05015 | -0.83317 | -0.15765 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | ||
Diluted Normalized EPS | -0.57335 | -0.97291 | -0.7687 | -0.15343 |
Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | |
---|---|---|---|---|---|
Total revenue | 259.578 | 252.589 | 229.36 | 217.56 | 209.527 |
Revenue | 259.578 | 252.589 | 229.36 | 217.56 | 209.527 |
Total Operating Expense | 307.994 | 286.768 | 275.587 | 256.609 | 270.018 |
Selling/General/Admin. Expenses, Total | 101.557 | 84.334 | 89.237 | 80.382 | 102.708 |
Depreciation / Amortization | 19.53 | 19.069 | 18.887 | 17.884 | 16.743 |
Unusual Expense (Income) | 0.3 | 0.378 | 0.795 | 1.076 | 0.87 |
Other Operating Expenses, Total | 186.607 | 182.987 | 166.668 | 157.267 | 149.697 |
Operating Income | -48.416 | -34.179 | -46.227 | -39.049 | -60.491 |
Interest Income (Expense), Net Non-Operating | -5.119 | -5.092 | -5.165 | -4.189 | -7.133 |
Other, Net | 1.515 | 0.992 | -2.324 | 1.032 | -0.18 |
Net Income Before Taxes | -52.02 | -38.279 | -53.716 | -42.206 | -67.804 |
Net Income After Taxes | -45.478 | -34.242 | -46.656 | -37.853 | -68.727 |
Net Income Before Extra. Items | -45.478 | -34.242 | -46.656 | -37.853 | -68.727 |
Net Income | -45.478 | -34.242 | -46.656 | -37.853 | -68.727 |
Total Adjustments to Net Income | 0 | 0 | 0 | ||
Income Available to Common Excl. Extra. Items | -45.478 | -34.242 | -46.656 | -37.853 | -68.727 |
Income Available to Common Incl. Extra. Items | -45.478 | -34.242 | -46.656 | -37.853 | -68.727 |
Diluted Net Income | -45.478 | -34.242 | -46.656 | -37.853 | -68.727 |
Diluted Weighted Average Shares | 363.161 | 360.902 | 358.941 | 357.52 | 353.729 |
Diluted EPS Excluding Extraordinary Items | -0.12523 | -0.09488 | -0.12998 | -0.10588 | -0.19429 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | 0 | |
Diluted Normalized EPS | -0.10751 | -0.09222 | -0.12564 | -0.10257 | -0.19269 |
- Annual
- Quarterly
2022 | 2021 | 2020 | 2019 | |
---|---|---|---|---|
Total Current Assets | 233.223 | 266.52 | 76.28 | 27.425 |
Cash and Short Term Investments | 108.621 | 148.029 | 18.829 | 3.481 |
Cash & Equivalents | 108.621 | 148.029 | 18.829 | 3.481 |
Total Receivables, Net | 101.508 | 94.695 | 46.934 | 19.13 |
Accounts Receivable - Trade, Net | 100.868 | 76.078 | 43.706 | 18.633 |
Prepaid Expenses | 12.097 | 19.454 | 10.517 | 4.814 |
Total Assets | 2173.87 | 1927.11 | 1569.73 | 280.779 |
Property/Plant/Equipment, Total - Net | 393.62 | 152.242 | 59.349 | 22.426 |
Property/Plant/Equipment, Total - Gross | 436.503 | 171.768 | 63.781 | 26.717 |
Accumulated Depreciation, Total | -42.883 | -19.526 | -4.432 | -4.291 |
Goodwill, Net | 1272.94 | 1204.54 | 1098.66 | 214.614 |
Intangibles, Net | 263.294 | 300.355 | 332.796 | 14.951 |
Other Long Term Assets, Total | 10.795 | 3.448 | 2.647 | 1.363 |
Total Current Liabilities | 175.999 | 116.752 | 75.921 | 55.007 |
Accounts Payable | 12.285 | 14.152 | 7.688 | 3.642 |
Accrued Expenses | 132.817 | 76.055 | 46.98 | 23.545 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 |
Other Current Liabilities, Total | 28.552 | 25.222 | 17.515 | 27.82 |
Total Liabilities | 655.148 | 382.081 | 536.895 | 144.221 |
Total Long Term Debt | 225.079 | 157.416 | 362.534 | 79.314 |
Long Term Debt | 225.079 | 157.416 | 362.534 | 79.314 |
Deferred Income Tax | 38.701 | 54.281 | 81.226 | 0.863 |
Other Liabilities, Total | 215.369 | 53.632 | 17.214 | 9.037 |
Total Equity | 1518.72 | 1545.03 | 1032.84 | 136.558 |
Preferred Stock - Non Redeemable, Net | 0 | 0 | 302.913 | |
Common Stock | 3.761 | 3.743 | 1044.51 | 0.003 |
Additional Paid-In Capital | 2084.32 | 1898.36 | 1.452 | 0 |
Retained Earnings (Accumulated Deficit) | -572.636 | -357.072 | -13.125 | -166.358 |
Total Liabilities & Shareholders’ Equity | 2173.87 | 1927.11 | 1569.73 | 280.779 |
Total Common Shares Outstanding | 375.964 | 374.255 | 373.649 | 373.649 |
Current Port. of LT Debt/Capital Leases | 2.345 | 1.323 | 3.738 | |
Other Current Assets, Total | 10.997 | 4.342 | ||
Other Equity, Total | 3.274 |
Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | |
---|---|---|---|---|---|
Total Current Assets | 264.25 | 237.881 | 212.509 | 233.223 | 252.587 |
Cash and Short Term Investments | 42.605 | 79.605 | 68.294 | 108.621 | 90.336 |
Cash & Equivalents | 42.605 | 79.605 | 68.294 | 108.621 | 90.336 |
Total Receivables, Net | 149.716 | 121.796 | 118.382 | 100.868 | 113.284 |
Accounts Receivable - Trade, Net | 149.716 | 121.796 | 118.382 | 100.868 | 113.284 |
Prepaid Expenses | 71.929 | 36.48 | 25.833 | 23.734 | 48.967 |
Total Assets | 2175.07 | 2170.92 | 2158.56 | 2173.87 | 1979.66 |
Property/Plant/Equipment, Total - Net | 370.752 | 384.525 | 389.704 | 393.62 | 193.393 |
Property/Plant/Equipment, Total - Gross | 434.822 | 442.872 | 440.437 | 436.503 | 232.82 |
Accumulated Depreciation, Total | -64.07 | -58.347 | -50.733 | -42.883 | -39.427 |
Goodwill, Net | 1293.43 | 1293.5 | 1293.61 | 1272.94 | 1249.79 |
Intangibles, Net | 233.615 | 243.788 | 253.964 | 263.294 | 272.473 |
Other Long Term Assets, Total | 13.023 | 11.221 | 8.772 | 10.795 | 11.416 |
Total Current Liabilities | 240.874 | 180.854 | 181.141 | 175.999 | 112.272 |
Accounts Payable | 10.4 | 8.044 | 7.709 | 12.285 | 7.947 |
Accrued Expenses | 218.252 | 158.938 | 157.342 | 144.902 | 90.879 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities, Total | 9.627 | 11.277 | 13.745 | 16.467 | 11.301 |
Total Liabilities | 720.018 | 676.041 | 653.433 | 655.148 | 448.159 |
Total Long Term Debt | 248.371 | 248.718 | 224.761 | 225.079 | 212.042 |
Long Term Debt | 248.371 | 248.718 | 224.761 | 225.079 | 212.042 |
Deferred Income Tax | 38.403 | 38.324 | 37.569 | 38.701 | 55.408 |
Other Liabilities, Total | 192.37 | 208.145 | 209.962 | 215.369 | 68.437 |
Total Equity | 1455.05 | 1494.88 | 1505.13 | 1518.72 | 1531.5 |
Common Stock | 3.788 | 3.782 | 3.767 | 3.761 | 3.761 |
Additional Paid-In Capital | 2162.77 | 2141.25 | 2108.18 | 2084.32 | 2050.54 |
Retained Earnings (Accumulated Deficit) | -715.887 | -654.304 | -608.826 | -572.636 | -525.98 |
Total Liabilities & Shareholders’ Equity | 2175.07 | 2170.92 | 2158.56 | 2173.87 | 1979.66 |
Total Common Shares Outstanding | 378.607 | 378.005 | 376.537 | 375.964 | 376.042 |
Current Port. of LT Debt/Capital Leases | 2.595 | 2.595 | 2.345 | 2.345 | 2.145 |
Preferred Stock - Non Redeemable, Net | 0 | ||||
Other Equity, Total | 4.381 | 4.151 | 2.004 | 3.274 | 3.185 |
- Annual
- Quarterly
2022 | 2021 | 2020 | 2019 | |
---|---|---|---|---|
Net income/Starting Line | -215.564 | -307.197 | -38.07 | 5.669 |
Cash From Operating Activities | 52.789 | 9.42 | -8.533 | 17.048 |
Cash From Operating Activities | 69.198 | 54.136 | 31.045 | 6.095 |
Deferred Taxes | -16.733 | -26.945 | -6.501 | 1.76 |
Non-Cash Items | 232.826 | 287.286 | 5.746 | 0.532 |
Cash Taxes Paid | 2.237 | 1.093 | 0.246 | 0.254 |
Cash Interest Paid | 14.365 | 22.415 | 17.149 | 4.582 |
Changes in Working Capital | -16.938 | 2.14 | -0.753 | 2.992 |
Cash From Investing Activities | -139.461 | -194.076 | -861.169 | -73.375 |
Capital Expenditures | -79.255 | -94.492 | -38.066 | -14.314 |
Other Investing Cash Flow Items, Total | -60.206 | -99.584 | -823.103 | -59.061 |
Cash From Financing Activities | 47.264 | 313.856 | 912.274 | 48.463 |
Financing Cash Flow Items | -20.685 | -11.18 | 600.867 | -6.987 |
Issuance (Retirement) of Stock, Net | 0 | 549.905 | 20 | 0 |
Issuance (Retirement) of Debt, Net | 67.949 | -224.869 | 291.407 | 55.45 |
Net Change in Cash | -39.408 | 129.2 | 42.572 | -7.864 |
Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
---|---|---|---|---|---|
Net income/Starting Line | -34.242 | -215.564 | -168.908 | -131.055 | -62.328 |
Cash From Operating Activities | -7.89 | 52.789 | 16.871 | 11.141 | 3.308 |
Cash From Operating Activities | 19.069 | 69.198 | 50.311 | 32.427 | 15.684 |
Deferred Taxes | -16.733 | ||||
Non-Cash Items | 33.536 | 232.826 | 156.548 | 122.107 | 60.584 |
Cash Interest Paid | 5.059 | 14.365 | 9.518 | 4.927 | 3.091 |
Changes in Working Capital | -26.253 | -16.938 | -21.08 | -12.338 | -10.632 |
Cash From Investing Activities | -27.549 | -139.461 | -109.165 | -88.893 | -50.855 |
Capital Expenditures | -7.729 | -79.255 | -68.871 | -53.775 | -27.91 |
Other Investing Cash Flow Items, Total | -19.82 | -60.206 | -40.294 | -35.118 | -22.945 |
Cash From Financing Activities | -4.888 | 47.264 | 34.601 | 26.409 | 13.508 |
Financing Cash Flow Items | -4.302 | -20.685 | -20.034 | -18.752 | -6.161 |
Issuance (Retirement) of Stock, Net | 0 | 0 | 0 | ||
Issuance (Retirement) of Debt, Net | -0.586 | 67.949 | 54.635 | 45.161 | 19.669 |
Net Change in Cash | -40.327 | -39.408 | -57.693 | -51.343 | -34.039 |
Cash Taxes Paid | -0.013 | 2.237 | 1.78 | 0.86 | -0.06 |
Investor Name | Investor Type | Percent Outstanding | Shares Held | Shares change | Holdings Date | Turnover Rating |
---|---|---|---|---|---|---|
TPG Capital, L.P. | Private Equity | 46.371 | 175284635 | 0 | 2023-06-30 | LOW |
Summit Partners, L.P. | Private Equity | 12.099 | 45734703 | 0 | 2023-09-30 | LOW |
Fidelity Management & Research Company LLC | Investment Advisor | 6.1334 | 23184620 | 513142 | 2023-06-30 | LOW |
Lester (Michael K.) | Individual Investor | 5.2891 | 19993012 | -1502956 | 2022-12-31 | |
Silversmith Capital Partners | Private Equity | 5.1696 | 19541192 | 0 | 2023-04-14 | |
Qureshi (Danish J.) | Individual Investor | 2.5901 | 9790850 | -72398 | 2023-06-21 | LOW |
The Vanguard Group, Inc. | Investment Advisor/Hedge Fund | 1.9654 | 7429385 | 191892 | 2023-06-30 | LOW |
Booth (Gwendolyn H.) | Individual Investor | 1.7282 | 6532649 | -88798 | 2022-06-13 | |
BlackRock Institutional Trust Company, N.A. | Investment Advisor | 1.6825 | 6359801 | 1683735 | 2023-06-30 | LOW |
Gouk (Warren) | Individual Investor | 1.5379 | 5813204 | -38058 | 2023-09-01 | LOW |
Mullins (Kevin Michael) | Individual Investor | 1.3009 | 4917283 | -113333 | 2023-10-02 | LOW |
Brown Advisory | Investment Advisor/Hedge Fund | 1.0836 | 4096093 | 3226920 | 2023-09-30 | LOW |
Principal Global Investors (Equity) | Investment Advisor | 0.9862 | 3727796 | 24796 | 2023-06-30 | LOW |
Stockbridge Partners LLC | Investment Advisor/Hedge Fund | 0.9754 | 3687152 | -3049538 | 2023-06-30 | LOW |
Fidelity Institutional Asset Management | Investment Advisor | 0.856 | 3235619 | 88226 | 2023-06-30 | LOW |
Bessler (Robert) | Individual Investor | 0.8102 | 3062599 | 21905 | 2023-07-01 | LOW |
Rock Springs Capital Management LP | Hedge Fund | 0.7672 | 2900000 | 0 | 2023-06-30 | LOW |
Burdick (Kenneth A) | Individual Investor | 0.6246 | 2361110 | 2361110 | 2023-03-06 | LOW |
Geode Capital Management, L.L.C. | Investment Advisor/Hedge Fund | 0.5982 | 2261394 | 429132 | 2023-06-30 | LOW |
State Street Global Advisors (US) | Investment Advisor/Hedge Fund | 0.5569 | 2105143 | 653041 | 2023-06-30 | LOW |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 20
- 100
- 500
- 1000
- 10000
LifeStance Health Company profile
Track the Lifestance Health Group, Inc. stock price today and spot the best opportunities for profitable CFD trades.
LifeStance is a US company based in Scottsdale, Arizona that was founded in 2017. The business operates outpatient care facilities all over the United States, focusing specifically on mental health services to individuals of all ages.
LifeStance Health Group made its trading debut on 10 June 2021 in a highly anticipated initial public offering (IPO). The flotation raised $720 million with the company selling 40 million shares at $18 each. The LFST stock price trades under the NASDAQ ticker symbol LFST.
LifeStance is also backed by TPG Capital, a private equity firm with around $103 billion in assets. TPG acquired a majority interest in Lifestance Health in March 2020. The IPO valued LifeStance Health Group at over $7 billion.
Successful IPO
LifeStance Health Group IPO seems particularly well-timed, given the increasing focus on mental health during the COVID-19 global pandemic. LifeStance Health also offers digital telehealth services.
There is often plenty of initial excitement when IPOs are announced, but equally often that enthusiasm quickly wanes – some companies see their share price fall just days after going public. That doesn’t seem to be the case with LFST. The LifeStance Health Group share price closed up at $21.90 on its first day of trading – that’s an impressive increase of 21.67%. The stock price has since shown a solid base at $20, which is good news for those invested in the IPO.
While the LFST IPO was clearly successful, it’s important to note that the stock could be overvalued. If you are looking for strong profit margins, it’s worth considering that LFST reported a net loss in the first quarter of 2021.
Great growth so far
In the first three months of 2021, LifeStance Health made around $143 million in revenue, according to its filings. These also showed that the company made a net loss of $8.7 million over the same period.
While this number might seem uninspiring for a company valued in the billions, it’s also important to note that this is more revenue than LifeStance Health reported for the whole of 2018. This explosion in growth suggests that the company could have the potential to become a strong player in the mental healthcare sector.
Investment options
Follow the LFST stock chart in real-time and consider trading it with contracts for difference (CFDs). As always when investing, you should make your own analysis to see if LifeStance Health Group, Inc stock price is an attractive trading opportunity for you.
With CFDs, you can go long or short on the company’s shares and trace all the latest ups and downs of the LifeStance Health Group (LFST) share price using Capital.com’s proprietary CFD trading platform
Industry: | Healthcare Facilities & Services (NEC) |
4800 N. Scottsdale Road
Suite 6000
SCOTTSDALE
ARIZONA 85251
US
Income Statement
- Annual
- Quarterly
News

December RBA preview: no move expected at the final meeting of 2023
The RBA meets on Tuesday, 5th of December, 2023, at 2.30 PM (AEDT). We preview what to expect from this month’s decision.
14:47, 4 December 2023
CPI drops more than expected in Europe, Spain’s IBEX 35 looking to break pre-COVID highs
CPI drops more than expected in Europe, Spain’s IBEX 35 looking to break pre-COVID highs
12:39, 30 November 2023
Euro Zone CPI expected to continue dropping; economists warn about cutting too soon
EZ PI expected to drop further but speed of decline
08:16, 29 November 2023
A weaker Dollar drives gold higher
Gold prices have returned above $US2000 per ounce. We run through the factors driving gold and the commodity’s key technicals.
13:49, 28 November 2023
Q3 US Earnings Recap: Profits surprise to the upside, but outlook remains uncertain
US earnings for the third quarter were far better than expected. However, uncertainty about the outlook for company profits continues. We review the quarterly earnings and look ahead to what the markets expect from S&P 500 companies going forward.
13:20, 28 November 2023
RBNZ Preview: Rates expected to remain unchanged at final meeting of 2023
The RBNZ meets for the final time this year on Wednesday, 29th of November, 2023. We preview what to expect and how it could impact the New Zealand Dollar.
13:04, 28 November 2023
Crude prices slide on OPEC+ uncertainty
Crude prices have chopped sideways amid signs of turmoil within OPEC+. We look at the fundamentals of the oil market and the technical levels of WTI.
12:55, 28 November 2023People also watch
Still looking for a broker you can trust?
Join the 570.000+ traders worldwide that chose to trade with Capital.com